Current status of liver transplantation

Archives of Iranian Medicine

Volumn 15, Issue 12, 2012, Pages 772-776

  Saidi, Reza F ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Immunosuppression; Indications; Liver transplantation; Outcomes; Results

Indexed keywords

ALEMTUZUMAB; AZATHIOPRINE; BASILIXIMAB; BILIRUBIN; CALCINEURIN INHIBITOR; CORTICOSTEROID; CREATININE; DACLIZUMAB; INTERLEUKIN 2 RECEPTOR ANTIBODY; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; THYMOCYTE ANTIBODY;

ABDOMINAL ABSCESS; BILE LEAKAGE; BONE MARROW SUPPRESSION; CADAVER DONOR; CHILD SCORE; CHOLESTASIS; CORTICOSTEROID INDUCED OSTEOPOROSIS; CUSHING SYNDROME; DIABETES MELLITUS; DISEASE SEVERITY; DRUG WITHDRAWAL; FOLLOW UP; GASTROINTESTINAL SYMPTOM; GRAFT DYSFUNCTION; GRAFT SURVIVAL; HEART DEATH; HEPATIC ARTERY THROMBOSIS; HEPATITIS C; HUMAN; HYPERKALEMIA; HYPERLIPIDEMIA; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INTERNATIONAL NORMALIZED RATIO; IRAN; LIVER FAILURE; LIVER GRAFT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVER VEIN THROMBOSIS; LIVING DONOR; LYMPHOPROLIFERATIVE DISEASE; MODEL OF END STAGE LIVER DISEASE; MORTALITY; NEPHROTOXICITY; NEUROTOXICITY; OPPORTUNISTIC INFECTION; PORTAL VEIN THROMBOSIS; POSTOPERATIVE INFECTION; PROGNOSIS; REVIEW; SCORING SYSTEM; SMALL FOR SIZE SYNDROME; SURVIVAL RATE;

FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; LIVING DONORS; POSTOPERATIVE COMPLICATIONS; TREATMENT OUTCOME;

EID: 84871209871     PISSN: 10292977     EISSN: 17353947     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Starzl TE, Groth CG, Brettschneider L, Penn I, Fulginiti VA, Moon JB, et al. Orthotopic homotransplantation of the human liver. Ann Surg. 1968; 168: 392-415
2. Strong RW, Lynch SV, Ong TH, Matsunami H, Koido Y Balderson GA. Successful liver transplantation from a living donor to her son. N Engl J Med. 1990; 322: 1505-1507.
3. Nikeghbalian S, Aliakbarian M, Kazemi K, Shamsaee Far A, Salehipour M, Bahreini A, et al. Clinical experience in organ transplant from the shiraz transplant center: 2011. Exp Clin Transplant. 2012; 10: 307-309.
4. Saidi RF. The Faltering solid organ donor pool in the United States. World J Surg. Aug 30, 2012 [In press].
5. Strasberg SM, Howard TK, Molmenti EP, Hertl M. Selecting the donor liver: risk factors for poor function after orthotopic liver transplanta-tion. Hepatology. 1994; 20: 829-838.
6. Mehrabi A, Fonouni H, Müller SA, Schmidt J. Current concepts in transplant surgery: liver transplantation today. LangenbecksArch Surg. 2008; 393: 245-260.
7. Busuttil RW, Tanaka K. The utility of marginal donors in liver transplantation. Liver Transplant. 2003; 9: 651-663.
8. Hashimoto K, Miller C. The use of marginal grafts in liver transplanta-tion. J Hepatobiliary Pancreat Surg. 2008; 15: 92-101.
9. Ben-Haim M, Emre S, Fishbein TM, Sheiner PA, Bodian CA, Kim-Schluger L, et al. Critical graft size in adult-to-adult living donor liver transplantation: impact of the recipient's disease. Liver Transpl. 2001; 7: 948-953.
10. Marcos A, Fisher RA, Ham JM, Shiffman ML, Sanyal AJ, Luketic VA, et al. Right lobe living donor liver transplantation. Transplantation. 1999; 68: 798-803.
11. Saidi RF, Jabbour N, Li Y, Shah SA, Bozorgzadeh A. Is left lobe adult-to-adult living donor liver transplantation ready for widespread use? The US experience (1998-2010). HPB (Oxford). 2012; 14: 455-460.
12. Rogiers X, Malago M, Gawad K, Jauch KW, Olausson M, Knoefel WT, et al. In situ splitting of cadaveric livers. The ultimate expansion of a limited donor pool. Ann Surg. 1996; 224: 331-339.
13. Ghobrial RM, Yersiz H, Farmer DG, Amersi F, Goss J, Chen P, et al. Predictors of survival after in vivo split liver transplantation: analysis of 110 consecutive patients. Ann Surg. 2000; 232: 312-323.
14. Kaufman DB, Shapiro R, Lucey MR, Cherikh WS, Ray TB, Dyke DB. Immunosuppression: practice and trends. Am J Transplant. 2004; 4(suppl 9): 38-53.
15. Settmacher U, Nussler NC, Glanemann M, Haase R, Heise M, Bechstein WO, et al. Venous complications after orthotopic liver transplantation. Clin Transplant. 2000; 14: 235-241.
16. Tung BY, Kimmey MB. Biliary complications of orthotopic liver transplantation. Dig Dis. 1999; 17: 133-144.
17. Saidi RF, Elias N, Ko DS, Kawai T, Markmann J, Cosimi AB, Hertl M. Biliary reconstruction and complications after living-donor liver transplantation. HPB. 2009; 11: 505-509.
18. Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med. 2007; 357: 2601-2614.
19. Johnson SR Alexopoulos S, Curry M, Hanto DW. Primary non function (PNF) in the MELD Era: an SRTR database analysis. Am J Transplant. 2007; 7: 1003-1009.
20. Thuluvath PJ, Guidinger MK, Fung JJ, Johnson LB, Rayhill SC, Pel-letier SJ. Liver transplantation in the United States, 1999-2008. Am J Transplant. 2010; 10: 1003-1019.